Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial (Q34648131)

3 August 2017

title

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial (English)

1 reference

multicenter clinical trial

3 August 2017

main subject

0 references

1 reference

M Suckfüll

1 reference

3 August 2017

Hearing Loss Study Group

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

360

1 reference

3 August 2017

issue

9348

1 reference

3 August 2017

page(s)

1811-1817

1 reference

Control of inner ear blood flow

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

A Randomized, Double-blind, Placebo-controlled Study of Dextran/Pentoxifylline Medication in Acute Acoustic Trauma and Sudden Hearing Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Audiometric and epidemiological analysis of elderly in the Veneto region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Sudden sensorineural hearing loss: does application of glucocorticoids make sense?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Blood viscosity and hearing levels in the Caerphilly Collaborative Heart Disease Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Is there a relationship between hypercholesterolaemia and noise-induced hearing loss?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Whole-blood filterability in sudden deafness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Blood viscosity and plasma viscosity in patients with sudden deafness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Influence of serum lipids on auditory function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

The effect of batroxobin on cochlear blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Hearing Recovery in Sudden Deafness Patients Using a Modified Defibrinogenation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Improvement of coronary vasodilatation capacity through single LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Comparative ototoxicity of cisplatin during acute and chronic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

Natural history of sudden sensorineural hearing loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911768-5

7 January 2021

10.1016/S0140-6736(02)11768-5

Identifiers

DOI

1 reference

3 August 2017

1 reference